Does Rallies show Form 4 insider transactions for ICUI?

Yes. Rallies tracks ICUI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ICUI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ICUI. It does not provide personalized investment advice.

ICUI (ICU Medical Inc) Stock Analysis - Insider Trades

ICU Medical Inc (ICUI) is a publicly traded Healthcare sector company. As of May 21, 2026, ICUI trades at $129.31 with a market cap of $3.08B and a P/E ratio of 67.68. ICUI moved +4.60% today. Year to date, ICUI is -10.28%; over the trailing twelve months it is -4.16%. Its 52-week range spans $107.00 to $196.26. Analyst consensus is buy with an average price target of $163.50. Rallies surfaces ICUI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ICUI stock inside the company?

Recent ICUI insider activity includes Sanzone Virginia Ruth sold 2.45K, Greenberg David C. sold 2.42K, Woolson Daniel sold 2.90K, FINNEY ELISHA W sold 1.28K, and Sanzone Virginia Ruth sold 930. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ICUI Key Metrics

Key financial metrics for ICUI
Metric	Value
Price	$129.31
Market Cap	$3.08B
P/E Ratio	67.68
EPS	$1.87
Dividend Yield	0.00%
52-Week High	$196.26
52-Week Low	$107.00
Volume	0
Avg Volume	0
Revenue (TTM)	$2.16B
Net Income	$46.34M
Gross Margin	37.93%

Recent ICUI Insider Trades

Sanzone Virginia Ruth sold 2.45K (~$303.62K) on May 14, 2026.
Greenberg David C. sold 2.42K (~$297.93K) on May 12, 2026.
Woolson Daniel sold 2.90K (~$441.36K) on Nov 25, 2025.
FINNEY ELISHA W sold 1.28K (~$180.44K) on Nov 11, 2025.
Sanzone Virginia Ruth sold 930 (~$132.38K) on Nov 11, 2025.

Latest ICUI News

ICU Medical Q4 EBITDA Down 7%, Integration Delays Keep 2026 Target Below $500M — Feb 20, 2026
ICU Medical Q4 Revenue Falls 13.8% to $535.9M While EPS Tops by 13.5% — Feb 20, 2026
ICU Medical Q4 Expected to Fall 14.6% to $530.9M, EPS $1.69 — Feb 18, 2026

ICUI Analyst Consensus

3 analysts cover ICUI: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $163.50.

Common questions about ICUI

Who is trading ICUI stock inside the company?: Recent ICUI insider activity includes Sanzone Virginia Ruth sold 2.45K, Greenberg David C. sold 2.42K, Woolson Daniel sold 2.90K, FINNEY ELISHA W sold 1.28K, and Sanzone Virginia Ruth sold 930. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ICUI?: Yes. Rallies tracks ICUI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ICUI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ICUI. It does not provide personalized investment advice.